Related Experiment Video
Updated: Aug 6, 2026

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
Published on: October 2, 2015
Pericardial mesothelioma
W T Vigneswaran1, P R Stefanacci
1Loyola University Medical Center Chicago and Stritch School of Medicine, 2160 South First Avenue, Maywood, IL 60153, USA.
Abstract:
Primary pericardial mesothelioma is a rare but lethal disease. Altogether there are about 150 cases reported in the literature. In most cases the diagnosis is made at autopsy or postoperatively. Clinical signs and symptoms are typically nonspecific and are similar to compromised cardiac function. Surgical resection remains the main treatment modality. When the disease is localized and completely resected, long-term survival can result. Most often the tumor invades the myocardium or the great vessels and therefore is at best palliative in relieving pericardial tamponade or constriction. Addition of chemotherapy or radiation has been disappointing. Newer therapeutic approaches for malignant pleural mesothelioma are likely to influence the treatment of pericardial mesothelioma in the future.
Insights
Primary pericardial mesothelioma is a rare, lethal cancer. Complete surgical removal offers the best chance for long-term survival, though diagnosis is often delayed and treatments are limited.
Area of Science:
- Oncology
- Cardiovascular Surgery
Background:
- Primary pericardial mesothelioma is an exceptionally rare and aggressive malignancy.
- Fewer than 150 cases are documented in medical literature.
- Diagnosis is frequently incidental, occurring post-mortem or during surgery.
Purpose of the Study:
- To review the clinical presentation, diagnostic challenges, and therapeutic strategies for primary pericardial mesothelioma.
- To highlight the prognostic factors influencing patient outcomes.
- To explore potential future treatment directions based on advancements in related malignancies.
Main Methods:
- Literature review of reported cases of primary pericardial mesothelioma.
- Analysis of clinical signs, symptoms, and diagnostic methods.
- Evaluation of surgical and non-surgical treatment outcomes.
Main Results:
- Nonspecific symptoms often mimic other cardiac conditions, delaying diagnosis.
- Surgical resection is the primary treatment, with long-term survival possible for localized, completely resected tumors.
- Tumor invasion into cardiac structures frequently renders complete resection impossible, limiting treatment to palliative care.
Conclusions:
- Complete surgical resection is crucial for favorable prognoses in primary pericardial mesothelioma.
- Current adjuvant therapies (chemotherapy, radiation) have shown limited efficacy.
- Emerging treatments for malignant pleural mesothelioma may offer future therapeutic avenues for pericardial mesothelioma.
Related Concept Videos
Pleural Disorders: Types and Brief Description
Myocarditis II: Clinical Features and Diagnostic Tests
Pericarditis I: Introduction
Pericarditis II: Clinical Features and Diagnostic Tests
Pericarditis III: Medical Management
Pericarditis IV: Nursing Management

